Galapagos NV (AMS:GLPG)
24.24
0.00 (0.00%)
Apr 29, 2026, 2:41 PM CET
Galapagos NV Revenue
In the year 2025, Galapagos NV had annual revenue of 1.11B EUR with 303.50% growth. Galapagos NV had revenue of 900.82M in the quarter ending December 31, 2025.
Revenue
1.11B
Revenue Growth
+303.50%
P/S Ratio
1.44
Revenue / Employee
1.58M
Employees
558
Market Cap
1.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.11B | 836.60M | 303.50% |
| Dec 31, 2024 | 275.65M | 35.93M | 14.99% |
| Dec 31, 2023 | 239.72M | -1.53M | -0.63% |
| Dec 31, 2022 | 241.25M | 6.87M | 2.93% |
| Dec 31, 2021 | 234.38M | -243.67M | -50.97% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Havas | 2.91B |
| Eurocommercial Properties | 284.00M |
| TKH Group | 1.76B |
| Basic-Fit | 1.42B |
| Fugro | 1.85B |
| Flow Traders | 820.82M |
| AMG Critical Materials | 1.45B |
| Koninklijke Heijmans | 2.77B |
Galapagos NV News
- 17 hours ago - Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026 - GlobeNewsWire
- 4 weeks ago - Galapagos NV Transcript: Collaboration - Transcripts
- 4 weeks ago - Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal - Nasdaq
- 4 weeks ago - Galapagos NV: Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - Finanz Nachrichten
- 4 weeks ago - Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 4 weeks ago - Galapagos NV: Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - Finanz Nachrichten
- 4 weeks ago - Galapagos NV: Galapagos Announces Nomination of Gino Santini to its Board of Directors - Finanz Nachrichten
- 4 weeks ago - Galapagos Announces Nomination of Gino Santini to its Board of Directors - GlobeNewsWire